Top Biomed Stock
Report Date: 03-17-2024
Symbol: DNTH - Dianthus Therapeutics, Inc.
Sector:
Industry:
Top Biomed Stock Signal: DNTH
Dianthus Therapeutics, Inc. (DNTH)
7 Times Square
New York, NY 10036
Phone: 929-999-4055
Website: https://dianthustx.com
CEO: Mr. Marino Garcia M.B.A.
Dianthus Therapeutics, Inc. operates as a clinical-stage biotechnology company that designs, develops, and delivers novel monoclonal antibodies for people living with severe autoimmune and inflammatory diseases. It develops DNTH103 that is in phase 1 clinical trails in patients with generalized myasthenia gravis, multifocal motor neuropathy, and chronic inflammatory demyelinating polyneuropathy. Dianthus Therapeutics, Inc. was incorporated in 2015 and is based in New York, New York.